88 related articles for article (PubMed ID: 27071151)
1. The use of a "gray zone" considering measurement uncertainty in pharmacological tests. The serum growth hormone stimulation test as an example.
Lazzati JM; Zaidman V; Maceiras M; Belgorosky A; Chaler E
Clin Chem Lab Med; 2016 Nov; 54(11):e349-e351. PubMed ID: 27071151
[No Abstract] [Full Text] [Related]
2. Commentary: Harmonizing growth hormone measurements: learning lessons for the future.
Wieringa GE; Trainer PJ
J Clin Endocrinol Metab; 2007 Aug; 92(8):2874-5. PubMed ID: 17682086
[No Abstract] [Full Text] [Related]
3. Central laboratory reassessment of IGF-I, IGF-binding protein-3, and GH serum concentrations measured at local treatment centers in growth-impaired children: implications for the agreement between outpatient screening and the results of somatotropic axis functional testing.
Hauffa BP; Lehmann N; Bettendorf M; Mehls O; Dörr HG; Stahnke N; Steinkamp H; Said E; Ranke MB;
Eur J Endocrinol; 2007 Nov; 157(5):597-603. PubMed ID: 17984239
[TBL] [Abstract][Full Text] [Related]
4. Harmonization of growth hormone measurement results: the empirical approach.
Ross HA; Lentjes EW; Menheere PM; Sweep CG;
Clin Chim Acta; 2014 May; 432():72-6. PubMed ID: 24508625
[TBL] [Abstract][Full Text] [Related]
5. Cut-off values of serum growth hormone (GH) in pharmacological stimulation tests (PhT) evaluated in short-statured children using a chemiluminescent immunometric assay (ICMA) calibrated with the International Recombinant Human GH Standard 98/574.
Chaler EA; Ballerini Ga; Lazzati JM; Maceiras M; Frusti M; Bergada I; Rivarola MA; Belgorosky A; Ropelato G
Clin Chem Lab Med; 2013 May; 51(5):e95-7. PubMed ID: 23095200
[No Abstract] [Full Text] [Related]
6. Is growth hormone stimulation testing in children still appropriate?
Gandrud LM; Wilson DM
Growth Horm IGF Res; 2004 Jun; 14(3):185-94. PubMed ID: 15125879
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency.
Biller BM; Samuels MH; Zagar A; Cook DM; Arafah BM; Bonert V; Stavrou S; Kleinberg DL; Chipman JJ; Hartman ML
J Clin Endocrinol Metab; 2002 May; 87(5):2067-79. PubMed ID: 11994342
[TBL] [Abstract][Full Text] [Related]
8. Statement 2: a growth hormone stimulation test should be done as part of the work-up for GHD.
Ten S
Pediatr Endocrinol Rev; 2008 Apr; 5 Suppl 3():837-40. PubMed ID: 18438326
[No Abstract] [Full Text] [Related]
9. Laboratory diagnosis of multiple pituitary hormone deficiencies: issues with testing of the growth and thyroid axes.
Nakamoto J
Pediatr Endocrinol Rev; 2009 Jan; 6 Suppl 2():291-7. PubMed ID: 19337184
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of serum insulin-like growth factor I assessment in the diagnosis of childhood-onset growth hormone deficiency.
Federico G; Cianfarani S
Horm Res Paediatr; 2010; 74(2):145-8. PubMed ID: 20551620
[TBL] [Abstract][Full Text] [Related]
11. Appropriate sampling times for growth hormone (GH) measurement during insulin tolerance testing (ITT) in children.
Muzsnai A; Sólyom J; Ilyés I; Kovács J; Sólyom E; Niederland T; Péter F
Horm Res; 2007; 68 Suppl 5():205-6. PubMed ID: 18174749
[TBL] [Abstract][Full Text] [Related]
12. [Provocative tests in the diagnosis of childhood onset growth hormone insufficiency].
Gonçalves JP; Correia F; Cardoso H; Borges T; Oliveira MJ
Acta Med Port; 2014; 27(5):587-92. PubMed ID: 25409214
[TBL] [Abstract][Full Text] [Related]
13. Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.
Abellan R; Ventura R; Palmi I; di Carlo S; Bacosi A; Bellver M; Olive R; Pascual JA; Pacifici R; Segura J; Zuccaro P; Pichini S
J Pharm Biomed Anal; 2008 Nov; 48(3):844-52. PubMed ID: 18617352
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children.
Ali A; Hashim R; Khan FA; Sattar A; Ijaz A; Manzoor SM; Younas M
J Ayub Med Coll Abbottabad; 2009; 21(3):40-5. PubMed ID: 20929010
[TBL] [Abstract][Full Text] [Related]
15. Managing quality vs. measuring uncertainty in the medical laboratory.
Westgard JO
Clin Chem Lab Med; 2010; 48(1):31-40. PubMed ID: 19919330
[TBL] [Abstract][Full Text] [Related]
16. Quantification of human growth hormone in serum with a labeled protein as an internal standard: essential considerations.
Pritchard C; Groves KJ; Biesenbruch S; O'Connor G; Ashcroft AE; Arsene C; Schulze D; Quaglia M
Anal Chem; 2014 Jul; 86(13):6525-32. PubMed ID: 24856175
[TBL] [Abstract][Full Text] [Related]
17. [Uncertainty of measurement].
Giroud C; Arnaud J; Vassault A;
Ann Biol Clin (Paris); 2010 Dec; 68 Spec No 1():237-45. PubMed ID: 21613020
[TBL] [Abstract][Full Text] [Related]
18. Sex hormone priming for growth hormone stimulation testing in pre- and early adolescent children is evidence based.
Rosenbloom AL
Horm Res Paediatr; 2011; 75(1):78-80. PubMed ID: 21252560
[No Abstract] [Full Text] [Related]
19. Responses to GHRH plus arginine test are more concordant with IGF-I circulating levels than responses to arginine and clonidine provocative tests.
Giacomozzi C; Spadoni GL; Pedicelli S; Scirè G; Cristofori L; Peschiaroli E; Deodati A; Cambiaso P; Cappa M; Cianfarani S
J Endocrinol Invest; 2012 Sep; 35(8):742-7. PubMed ID: 21978975
[TBL] [Abstract][Full Text] [Related]
20. An approach to establish the uncertainty budget of catalytic activity concentration measurements in a reference laboratory.
Rami L; Canalias F
Clin Chem Lab Med; 2015 Apr; 53(5):743-51. PubMed ID: 25283140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
